| Literature DB >> 34611033 |
Jian-Feng Qu1, Huo-Hua Zhong1, Wen-Cong Liang1, Yang-Kun Chen2, Yong-Lin Liu1, Wei Li1.
Abstract
The aim of the present study was to determine the neuroimaging predictors of poor participation after acute ischemic stroke. A total of 443 patients who had acute ischemic stroke were assessed. At 1-year recovery, the Reintegration to Normal Living Index was used to assess participation restriction. We also assessed the Activities of Daily Living Scale and modified Rankin Scale (mRS) score. Brain MRI measurement included acute infarcts and pre-existing abnormalities such as enlarged perivascular spaces, white matter lesions, ventricular-brain ratio, and medial temporal lobe atrophy (MTLA). The study included 324 men (73.1%) and 119 women (26.9%). In the univariate analysis, patients with poor participation after 1 year were older, more likely to be men, had higher National Institutes of Health Stroke Scale (NIHSS) score on admission, with more histories of hypertension and atrial fibrillation, larger infarct volume, more severely enlarged perivascular spaces and MTLA, and more severe periventricular hyperintensities and deep white matter hyperintensities. Patients with participation restriction also had poor activities of daily living (ADL) and mRS score. Multiple logistic regression showed that, in model 1, age, male gender, NIHSS score on admission, and ADL on follow-up were significant predictors of poor participation, accounting for 60.2% of the variance. In model 2, which included both clinical and MRI variables, male gender, NIHSS score on admission, ADL on follow-up, and MTLA were significant predictors of poor participation, accounting for 61.2% of the variance. Participation restriction was common after acute ischemic stroke despite good mRS score. Male gender, stroke severity, severity of ADL on follow-up, and MTLA may be predictors of poor participation. Trial registration number ChiCTR1800016665. © American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.Entities:
Keywords: stroke
Mesh:
Year: 2021 PMID: 34611033 PMCID: PMC8819659 DOI: 10.1136/jim-2020-001675
Source DB: PubMed Journal: J Investig Med ISSN: 1081-5589 Impact factor: 2.895
Figure 1Flow chart of participants. mRS, modified Rankin Scale.
Demographic and clinical characteristics of the study patients
| Characteristics | N=443 |
| Age (years)* | 59.61 (11.59) |
| Male† | 324 (73.1) |
| NIHSS score on admission‡ | 2 (1–3) |
| Time of onset to admission* | 23.2 (31.3) |
| Hypertension† | 324 (73.1) |
| Diabetes mellitus† | 132 (29.8) |
| Atrial fibrillation† | 26 (5.9) |
| Previous stroke† | 33 (7.5) |
| Intravenous thrombolysis† | 23 (5.2) |
| Stroke subtype† | |
| Large artery | 138 (31.2) |
| Small artery | 198 (44.7) |
| Cardioembolism | 25 (5.6) |
| Other etiologies | 10 (2.3) |
| Unknown etiologies | 72 (16.3) |
| Location of infarcts | |
| Cortical region† | 172 (38.8) |
| Subcortical region† | 302 (68.2) |
| Infratentorial region† | 87 (19.6) |
| Infarct volume‡ | 1.1 (0.5–3.4) |
| BG-EPVS‡ | 1 (0–2) |
| CS-EPVS‡ | 1 (1–2) |
| PVH‡ | 1 (0–2) |
| DWMH‡ | 1 (0–1) |
| VBR* | 20.3 (5.9) |
| MTLA‡ | 0 (0–2) |
| RNLI score on follow-up‡ | 103 (98–106) |
| ADL on follow-up‡ | 14 (14–15) |
| mRS score on follow up‡ | 1 (0–1) |
*Mean (SD).
†n (%).
‡Median (IQR).
ADL, activities of daily living; BG-EPVS, enlarged perivascular spaces in the basal ganglia; CS-EPVS, enlarged perivascular spaces in the centrum semiovale; DWMH, deep white matter hyperintensities; mRS, modified Rankin Scale; MTLA, medial temporal lobe atrophy; NIHSS, National Institutes of Health Stroke Scale; PVH, periventricular hyperintensities; RNLI, Reintegration to Normal Living Index; VBR, ventricular-brain ratio.
Risk factors for poor participation at 1-year follow-up in the univariate analysis
| Poor participation | Favorable participation | t/z/χ2 | P value | |
| Age (years)* | 65.56 (10.95) | 57.74 (11.17) | −6.313 | <0.001 |
| Male† | 68 (64.2) | 256 (76) | 5.728 | 0.017 |
| NIHSS score on admission‡ | 3 (2–4) | 2 (1–3) | −3.418 | 0.001 |
| Time of onset to admission* | 26.5 (34.5) | 22.2 (30.2) | −1.223 | 0.222 |
| Hypertension† | 87 (82.1) | 237 (70.3) | 5.666 | 0.017 |
| Diabetes mellitus† | 39 (36.8) | 93 (27.6) | 3.26 | 0.071 |
| Atrial fibrillation† | 12 (11.3) | 14 (4.2) | 7.496 | 0.006 |
| Previous stroke† | 12 (11.3) | 21 (6.3) | 2.999 | 0.083 |
| Intravenous thrombolysis† | 7 (6.6) | 16 (4.7) | 0.564 | 0.453 |
| Stroke subtype† | 18.79 | 0.001 | ||
| Large artery | 44 (41.5) | 94 (27.9) | ||
| Small artery | 37 (34.9) | 161 (47.8) | ||
| Cardioembolism | 12 (11.3) | 13 (3.9) | ||
| Other etiologies | 2 (1.9) | 8 (2.4) | ||
| Unknown etiologies | 11 (10.4) | 61 (18.1) | ||
| Location of infarcts | ||||
| Cortical region† | 46 (43.4) | 126 (37.4) | 1.225 | 0.268 |
| Subcortical region† | 73 (68.9) | 229 (68.2) | 0.019 | 0.891 |
| Infratentorial region† | 21 (19.8) | 66 (19.6) | 0.001 | 0.97 |
| Infarct volume‡ | 2.17 (0.64–6.07) | 0.98 (0.4–3.04) | −3.287 | 0.001 |
| BG-EPVS‡ | 1 (1–2) | 1 (0–2) | −2.436 | 0.015 |
| CS-EPVS‡ | 1 (1–2) | 1 (1–2) | −1.998 | 0.046 |
| PVH‡ | 1 (1–2) | 1 (0–2) | −2.729 | 0.006 |
| DWMH‡ | 1 (0–2) | 1 (0–1) | −3.287 | 0.001 |
| VBR* | 20.7 (4.1) | 20.2 (6.4) | −0.691 | 0.49 |
| MTLA‡ | 1 (0–3) | 0 (0–1) | −4.595 | <0.001 |
| ADL on follow-up‡ | 18 (15–29.5) | 14 (14–14) | −14.699 | <0.001 |
| mRS score on follow-up‡ | 2 (1–3) | 0 (0–1) | −10.94 | <0.001 |
*Mean (SD), t-test.
†n (%), χ2 test.
‡Median (Qu–QL), Mann-Whitney U test.
ADL, activities of daily living; BG-EPVS, enlarged perivascular spaces in the basal ganglia; CS-EPVS, enlarged perivascular spaces in the centrum semiovale; DWMH, deep white matter hyperintensities; mRS, modified Rankin Scale; MTLA, medial temporal lobe atrophy; NIHSS, National Institutes of Health Stroke Scale; PVH, periventricular hyperintensities; VBR, ventricular-brain ratio.
Multivariate logistic regression of risk factors for poor participation
| Variables | β | OR (95% CI) | P value | R2 |
| Model 1 (without MRI variables) | 0.602 | |||
| Age (years) | 0.31 | 1.031 (1.002 to 1.062) | 0.038 | |
| Male | 0.745 | 2.105 (1.078 to 4.112) | 0.029 | |
| NIHSS score on admission | 0.184 | 1.202 (1.053 to 1.372) | 0.006 | |
| Hypertension | 0.198 | 1.219 (0.562 to 5.825) | 0.362 | |
| Atrial fibrillation | 0.538 | 1.713 (0.516 to 5.689) | 0.38 | |
| Stroke subtype | −0.162 | 0.85 (0.661 to 1.093) | 0.205 | |
| ADL on follow-up | 0.962 | 2.617 (1.933 to 3.543) | <0.001 | |
| Model 2 (with MRI variables) | 0.612 | |||
| Age | 0.016 | 1.016 (0.985 to 1.049) | 0.311 | |
| Male | 0.831 | 2.296 (1.158 to 4.553) | 0.017 | |
| NIHSS score on admission | 0.184 | 1.202 (1.056 to 1.369) | 0.005 | |
| Hypertension | 0.181 | 1.199 (0.55 to 2.613) | 0.649 | |
| Atrial fibrillation | 0.492 | 1.635 (0.477 to 5.608) | 0.434 | |
| Stroke subtype | −0.156 | 0.855 (0.666 to 1.098) | 0.22 | |
| Infarct volume | <0.001 | 1 (0.997 to 1.003) | 0.912 | |
| BG-EPVS | 0.008 | 1.008 (0.727 to 1.396) | 0.963 | |
| DWMH | 0.032 | 1.033 (0.683 to 1.561) | 0.878 | |
| MTLA | 0.235 | 1.265 (1.069 to 1.497) | 0.006 | |
| ADL on follow-up | 1.001 | 2.721 (2.018 to 3.671) | <0.001 | |
| MTLA by age | −0.004 | 0.996 (0.981 to 1.059) | 0.577 | |
ADL, activities of daily living; BG-EPVS, enlarged perivascular spaces in the basal ganglia; DWMH, deep white matter hyperintensities; MTLA, medial temporal lobe atrophy; NIHSS, National Institutes of Health Stroke Scale.